drugset / Trial / NCT02701374

Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia

NCT02701374 ↗

Phase 2 Completed 184 enrolled Toray Industries, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

In Post-Herpetic Neuralgia(PHN) patients: * To conduct an explorative investigation of the efficacy and safety of repeated oral doses of TRK-700 via a randomized double blind comparative study * To measure the plasma concentration of TRK-700 and its metabolites

Timeline

Start
2016-03
Primary completion
2017-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject TRK-700 Unknown — Oral